Pancreatic Cancer Research

ResearcherUniversity of MiamiActive in the last 2 years

Erin M. Dickey

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5093760618. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2024: 3 papers · 2025: 2 papers · 2026: 4 papers

Papers 9

  1. Trend of Adjuvant Radiation in Resected Pancreatic Ductal Adenocarcinoma: Evaluation of RTOG 0848 with a Large National Database. Co-author DOI 10.1007/s12029-026-01492-0↗
  2. IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancer. Co-author DOI 10.1172/jci.insight.202487↗
  3. Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18664-0↗
  4. ASO Visual Abstract: Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18846-w↗
  5. Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancer. First author DOI 10.1002/cncr.70130↗
  6. SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multic… Co-author DOI 10.1097/sla.0000000000006966↗
  7. Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional ana… First author DOI 10.1002/jso.27798↗
  8. Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer. Co-author DOI 10.1080/2162402x.2024.2326694↗
  9. Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer. Co-author DOI 10.21037/hbsn-23-668↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nipun B. Merchant · 7 shared papers, 2024–2026 · strength 1.61
  2. Peter J. Hosein · 6 shared papers, 2024–2026 · strength 1.50
  3. Caitlin A. Hester · 6 shared papers, 2024–2026 · strength 1.35
  4. Jashodeep Datta · 5 shared papers, 2024–2026 · strength 1.25
  5. Mary P Martos · 5 shared papers, 2024–2026 · strength 1.16
  6. Haleh Amirian · 4 shared papers, 2024–2026 · strength 0.89
  7. Jashodeep Datta · 3 shared papers, 2024–2025 · strength 0.60
  8. Gretel Terrero · 2 shared papers, 2026 · strength 0.56
  9. Anna Bianchi · 2 shared papers, 2024–2026 · strength 0.50
  10. Neda Amini · 1 shared paper, 2026 · strength 0.39
  11. Joseph Blansfield · 1 shared paper, 2026 · strength 0.39
  12. David A. Kooby · 2 shared papers, 2024–2025 · strength 0.37
  13. Alexander A. Parikh · 2 shared papers, 2024–2025 · strength 0.37
  14. Daniel Erik Abbott · 2 shared papers, 2024–2025 · strength 0.37
  15. Syed Nabeel Zafar · 2 shared papers, 2024–2025 · strength 0.37
  16. Shishir Kumar Maithel · 2 shared papers, 2024–2025 · strength 0.37
  17. Syed Ameen Ahmad · 1 shared paper, 2025 · strength 0.21
  18. Kawther Abdilleh · 1 shared paper, 2025 · strength 0.21
  19. Julia Button · 1 shared paper, 2025 · strength 0.19
  20. David G. Brauer · 1 shared paper, 2025 · strength 0.19
  21. Michael E. Lidsky · 1 shared paper, 2025 · strength 0.19
  22. Brian E. Diskin · 1 shared paper, 2025 · strength 0.19
  23. Elishama N. Kanu · 1 shared paper, 2025 · strength 0.19
  24. Ethan S. Agritelley · 1 shared paper, 2025 · strength 0.19
  25. Emil Lou · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.